MAPT and Alzheimer disease: In fact, it should be reported that cerebrospinal fluid (CSF) concentrations of Aβ42, total tau (t-tau), and hyperphosphorylated tau (p-tau) proteins have been validated as “core” biomarkers of AD pathophysiology.